Miller DH - Search Results

1

Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods.

Anderson VM, Fernando KT, Davies GR, Rashid W, Frost C, Fox NC, Miller DH. Anderson VM, et al. Among authors: miller dh. J Neuroimaging. 2007 Jan;17(1):61-8. doi: 10.1111/j.1552-6569.2006.00081.x. J Neuroimaging. 2007. PMID: 17238871

2

Early prognosis of multiple sclerosis.

Swanton J, Fernando K, Miller D. Swanton J, et al. Handb Clin Neurol. 2014;122:371-91. doi: 10.1016/B978-0-444-52001-2.00015-7. Handb Clin Neurol. 2014. PMID: 24507526 Review.

3

New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes.

Dalton CM, Brex PA, Miszkiel KA, Fernando K, MacManus DG, Plant GT, Thompson AJ, Miller DH. Dalton CM, et al. Among authors: miller dh. Ann Neurol. 2003 May;53(5):673-6. doi: 10.1002/ana.10580. Ann Neurol. 2003. PMID: 12731004

4

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.

Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K, Plant GT, Thompson AJ, Miller DH. Dalton CM, et al. Among authors: miller dh. Brain. 2004 May;127(Pt 5):1101-7. doi: 10.1093/brain/awh126. Epub 2004 Mar 3. Brain. 2004. PMID: 14998914

5

Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size.

Rashid W, Davies GR, Chard DT, Griffin CM, Altmann DR, Gordon R, Kapoor R, Thompson AJ, Miller DH. Rashid W, et al. Among authors: miller dh. J Magn Reson Imaging. 2006 Apr;23(4):473-6. doi: 10.1002/jmri.20545. J Magn Reson Imaging. 2006. PMID: 16521094

6

Magnetic resonance imaging measures of brain atrophy in multiple sclerosis.

Anderson VM, Fox NC, Miller DH. Anderson VM, et al. Among authors: miller dh. J Magn Reson Imaging. 2006 May;23(5):605-18. doi: 10.1002/jmri.20550. J Magn Reson Imaging. 2006. PMID: 16596564 Review.

7

Localization of grey matter atrophy in early RRMS : A longitudinal study.

Audoin B, Davies GR, Finisku L, Chard DT, Thompson AJ, Miller DH. Audoin B, et al. Among authors: miller dh. J Neurol. 2006 Nov;253(11):1495-501. doi: 10.1007/s00415-006-0264-2. Epub 2006 Nov 8. J Neurol. 2006. PMID: 17093899

8

A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis.

Soon D, Altmann DR, Fernando KT, Giovannoni G, Barkhof F, Polman CH, O'Connor P, Gray B, Panzara M, Miller DH. Soon D, et al. Among authors: miller dh. J Neurol. 2007 Mar;254(3):306-14. doi: 10.1007/s00415-006-0356-z. Epub 2007 Feb 3. J Neurol. 2007. PMID: 17277910 Clinical Trial.

9

Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates.

Anderson VM, Bartlett JW, Fox NC, Fisniku L, Miller DH. Anderson VM, et al. Among authors: miller dh. J Neurol. 2007 Nov;254(11):1588-94. doi: 10.1007/s00415-007-0599-3. Epub 2007 Oct 25. J Neurol. 2007. PMID: 17940723 Clinical Trial.

10

Recent advances in neuroimaging of multiple sclerosis.

Rashid W, Miller DH. Rashid W, et al. Among authors: miller dh. Semin Neurol. 2008 Feb;28(1):46-55. doi: 10.1055/s-2007-1019127. Semin Neurol. 2008. PMID: 18256986 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,171 results

Search Page

Filters